1 Market Overview of Nuclear Drug for Therapeutic 1.1 Nuclear Drug for Therapeutic Market Overview 1.1.1 Nuclear Drug for Therapeutic Product Scope 1.1.2 Nuclear Drug for Therapeutic Market Status and Outlook 1.2 Global Nuclear Drug for Therapeutic Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Nuclear Drug for Therapeutic Market Size by Region (2016-2027) 1.4 Global Nuclear Drug for Therapeutic Historic Market Size by Region (2016-2021) 1.5 Global Nuclear Drug for Therapeutic Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Nuclear Drug for Therapeutic Market Size (2016-2027) 1.6.1 North America Nuclear Drug for Therapeutic Market Size (2016-2027) 1.6.2 Europe Nuclear Drug for Therapeutic Market Size (2016-2027) 1.6.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size (2016-2027) 1.6.4 Latin America Nuclear Drug for Therapeutic Market Size (2016-2027) 1.6.5 Middle East & Africa Nuclear Drug for Therapeutic Market Size (2016-2027) 2 Nuclear Drug for Therapeutic Market Overview by Type 2.1 Global Nuclear Drug for Therapeutic Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Nuclear Drug for Therapeutic Historic Market Size by Type (2016-2021) 2.3 Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2022-2027) 2.4 Radium-223 2.5 Lutetium-177 2.6 Iodine-131 2.7 Other 3 Nuclear Drug for Therapeutic Market Overview by Application 3.1 Global Nuclear Drug for Therapeutic Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Nuclear Drug for Therapeutic Historic Market Size by Application (2016-2021) 3.3 Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2022-2027) 3.4 Thyroid 3.5 Bone Metastasis 3.6 Lymphoma 3.7 Other 4 Nuclear Drug for Therapeutic Competition Analysis by Players 4.1 Global Nuclear Drug for Therapeutic Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2020) 4.3 Date of Key Players Enter into Nuclear Drug for Therapeutic Market 4.4 Global Top Players Nuclear Drug for Therapeutic Headquarters and Area Served 4.5 Key Players Nuclear Drug for Therapeutic Product Solution and Service 4.6 Competitive Status 4.6.1 Nuclear Drug for Therapeutic Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Bayer 5.1.1 Bayer Profile 5.1.2 Bayer Main Business 5.1.3 Bayer Nuclear Drug for Therapeutic Products, Services and Solutions 5.1.4 Bayer Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.1.5 Bayer Recent Developments 5.2 Novartis 5.2.1 Novartis Profile 5.2.2 Novartis Main Business 5.2.3 Novartis Nuclear Drug for Therapeutic Products, Services and Solutions 5.2.4 Novartis Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.2.5 Novartis Recent Developments 5.3 China Isotope & Radiation 5.5.1 China Isotope & Radiation Profile 5.3.2 China Isotope & Radiation Main Business 5.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Products, Services and Solutions 5.3.4 China Isotope & Radiation Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.3.5 Dongcheng Recent Developments 5.4 Dongcheng 5.4.1 Dongcheng Profile 5.4.2 Dongcheng Main Business 5.4.3 Dongcheng Nuclear Drug for Therapeutic Products, Services and Solutions 5.4.4 Dongcheng Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.4.5 Dongcheng Recent Developments 5.5 Q BioMed 5.5.1 Q BioMed Profile 5.5.2 Q BioMed Main Business 5.5.3 Q BioMed Nuclear Drug for Therapeutic Products, Services and Solutions 5.5.4 Q BioMed Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.5.5 Q BioMed Recent Developments 5.6 Curium Pharmaceuticals 5.6.1 Curium Pharmaceuticals Profile 5.6.2 Curium Pharmaceuticals Main Business 5.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Products, Services and Solutions 5.6.4 Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.6.5 Curium Pharmaceuticals Recent Developments 5.7 Jubilant DraxImage 5.7.1 Jubilant DraxImage Profile 5.7.2 Jubilant DraxImage Main Business 5.7.3 Jubilant DraxImage Nuclear Drug for Therapeutic Products, Services and Solutions 5.7.4 Jubilant DraxImage Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.7.5 Jubilant DraxImage Recent Developments 5.8 Lantheus 5.8.1 Lantheus Profile 5.8.2 Lantheus Main Business 5.8.3 Lantheus Nuclear Drug for Therapeutic Products, Services and Solutions 5.8.4 Lantheus Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.8.5 Lantheus Recent Developments 5.9 Spectrum Pharmaceuticals 5.9.1 Spectrum Pharmaceuticals Profile 5.9.2 Spectrum Pharmaceuticals Main Business 5.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Products, Services and Solutions 5.9.4 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.9.5 Spectrum Pharmaceuticals Recent Developments 5.10 Progenics Pharmaceuticals 5.10.1 Progenics Pharmaceuticals Profile 5.10.2 Progenics Pharmaceuticals Main Business 5.10.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Products, Services and Solutions 5.10.4 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.10.5 Progenics Pharmaceuticals Recent Developments 5.11 International Isotopes 5.11.1 International Isotopes Profile 5.11.2 International Isotopes Main Business 5.11.3 International Isotopes Nuclear Drug for Therapeutic Products, Services and Solutions 5.11.4 International Isotopes Nuclear Drug for Therapeutic Revenue (US$ Million) & (2016-2021) 5.11.5 International Isotopes Recent Developments 6 North America 6.1 North America Nuclear Drug for Therapeutic Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Nuclear Drug for Therapeutic Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Nuclear Drug for Therapeutic Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Nuclear Drug for Therapeutic Market Dynamics 11.1 Nuclear Drug for Therapeutic Industry Trends 11.2 Nuclear Drug for Therapeutic Market Drivers 11.3 Nuclear Drug for Therapeutic Market Challenges 11.4 Nuclear Drug for Therapeutic Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Nuclear Drug for Therapeutic Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Nuclear Drug for Therapeutic Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Nuclear Drug for Therapeutic Market Size Share by Region (2016-2021) Table 4. Global Nuclear Drug for Therapeutic Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Nuclear Drug for Therapeutic Forecasted Market Size Share by Region (2022-2027) Table 6. Global Nuclear Drug for Therapeutic Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Nuclear Drug for Therapeutic Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2016-2021) Table 9. Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2022-2027) Table 11. Global Nuclear Drug for Therapeutic Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Nuclear Drug for Therapeutic Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2016-2021) Table 14. Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2022-2027) Table 16. Global Nuclear Drug for Therapeutic Revenue (US$ Million) by Players (2016-2021) Table 17. Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2020) Table 19. Date of Key Manufacturers Enter into Nuclear Drug for Therapeutic Market Table 20. Global Nuclear Drug for Therapeutic Top Players Headquarters and Area Served Table 21. Nuclear Drug for Therapeutic Product Solution and Service Table 22. Global Nuclear Drug for Therapeutic Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Bayer Basic Information List Table 25. Bayer Description and Business Overview Table 26. Bayer Nuclear Drug for Therapeutic Products, Services and Solutions Table 27. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Bayer (2016-2021) Table 28. Bayer Recent Developments Table 29. Novartis Basic Information List Table 30. Novartis Description and Business Overview Table 31. Novartis Nuclear Drug for Therapeutic Products, Services and Solutions Table 32. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Novartis (2016-2021) Table 33. Novartis Recent Developments Table 34. China Isotope & Radiation Basic Information List Table 35. China Isotope & Radiation Description and Business Overview Table 36. China Isotope & Radiation Nuclear Drug for Therapeutic Products, Services and Solutions Table 37. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of China Isotope & Radiation (2016-2021) Table 38. China Isotope & Radiation Recent Developments Table 39. Dongcheng Basic Information List Table 40. Dongcheng Description and Business Overview Table 41. Dongcheng Nuclear Drug for Therapeutic Products, Services and Solutions Table 42. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Dongcheng (2016-2021) Table 43. Dongcheng Recent Developments Table 44. Q BioMed Basic Information List Table 45. Q BioMed Description and Business Overview Table 46. Q BioMed Nuclear Drug for Therapeutic Products, Services and Solutions Table 47. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Q BioMed (2016-2021) Table 48. Q BioMed Recent Developments Table 49. Curium Pharmaceuticals Basic Information List Table 50. Curium Pharmaceuticals Description and Business Overview Table 51. Curium Pharmaceuticals Nuclear Drug for Therapeutic Products, Services and Solutions Table 52. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Curium Pharmaceuticals (2016-2021) Table 53. Curium Pharmaceuticals Recent Developments Table 54. Jubilant DraxImage Basic Information List Table 55. Jubilant DraxImage Description and Business Overview Table 56. Jubilant DraxImage Nuclear Drug for Therapeutic Products, Services and Solutions Table 57. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Jubilant DraxImage (2016-2021) Table 58. Jubilant DraxImage Recent Developments Table 59. Lantheus Basic Information List Table 60. Lantheus Description and Business Overview Table 61. Lantheus Nuclear Drug for Therapeutic Products, Services and Solutions Table 62. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Lantheus (2016-2021) Table 63. Lantheus Recent Developments Table 64. Spectrum Pharmaceuticals Basic Information List Table 65. Spectrum Pharmaceuticals Description and Business Overview Table 66. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Products, Services and Solutions Table 67. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Spectrum Pharmaceuticals (2016-2021) Table 68. Spectrum Pharmaceuticals Recent Developments Table 69. Progenics Pharmaceuticals Basic Information List Table 70. Progenics Pharmaceuticals Description and Business Overview Table 71. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Products, Services and Solutions Table 72. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Progenics Pharmaceuticals (2016-2021) Table 73. Progenics Pharmaceuticals Recent Developments Table 74. International Isotopes Basic Information List Table 75. International Isotopes Description and Business Overview Table 76. International Isotopes Nuclear Drug for Therapeutic Products, Services and Solutions Table 77. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of International Isotopes (2016-2021) Table 78. International Isotopes Recent Developments Table 79. North America Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 80. North America Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 81. Europe Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 82. Europe Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 83. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2016-2021) & (US$ Million) Table 84. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2022-2027) & (US$ Million) Table 85. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2016-2021) Table 86. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2022-2027) Table 87. Latin America Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 88. Latin America Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 89. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Players (2016-2021) & (US$ Million) Table 90. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 91. Nuclear Drug for Therapeutic Market Trends Table 92. Nuclear Drug for Therapeutic Market Drivers Table 93. Nuclear Drug for Therapeutic Market Challenges Table 94. Nuclear Drug for Therapeutic Market Restraints Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Global Nuclear Drug for Therapeutic Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Nuclear Drug for Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Nuclear Drug for Therapeutic Market Share by Regions: 2021 VS 2027 Figure 4. Global Nuclear Drug for Therapeutic Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Nuclear Drug for Therapeutic Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Nuclear Drug for Therapeutic Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Nuclear Drug for Therapeutic Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Nuclear Drug for Therapeutic Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Nuclear Drug for Therapeutic Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Nuclear Drug for Therapeutic Market Size Share by Type in 2021 & 2027 Figure 11. Radium-223 Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Lutetium-177 Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Iodine-131 Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Global Nuclear Drug for Therapeutic Market Size Share by Application in 2021 & 2027 Figure 16. Thyroid Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Bone Metastasis Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Lymphoma Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Top 5 and Top 10 Players Nuclear Drug for Therapeutic Market Share in 2020 Figure 22. North America Nuclear Drug for Therapeutic Market Share by Country (2016-2027) Figure 23. United States Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 24. Canada Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 25. Germany Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 26. France Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 27. U.K. Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 28. Italy Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 29. Russia Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 30. Nordic Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 31. Rest of Europe Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 32. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2016-2027) Figure 33. China Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 34. Japan Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 35. South Korea Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 36. Southeast Asia Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 37. India Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 38. Australia Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 39. Rest of Asia-Pacific Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 40. Latin America Nuclear Drug for Therapeutic Market Share by Country (2016-2027) Figure 41. Mexico Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 42. Brazil Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 43. Rest of Latin America Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 44. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Country (2016-2027) Figure 45. Turkey Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 46. Saudi Arabia Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 47. UAE Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 48. Rest of Middle East & Africa Nuclear Drug for Therapeutic Market Size (2016-2027) & (US$ Million) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation

Bayer Novartis China Isotope & Radiation Dongcheng Q BioMed Curium Pharmaceuticals Jubilant DraxImage Lantheus Spectrum Pharmaceuticals Progenics Pharmaceuticals International Isotopes